World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
14777
World Ranking
3018
National Ranking
73

Louis A. Matis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Louis A. Matis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 136 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Louis A. Matis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Louis A. Matis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Louis A. Matis is a researcher affiliated with Alexion Pharma (Switzerland) in Switzerland. Their work spans multiple areas within medicine, particularly focusing on oncology, immunology, pulmonary and respiratory medicine, and radiology.

The main fields of study covered by Louis A. Matis include:

  • Medicine

They have contributed to several subfields, including:

  • Radiology, Nuclear Medicine and Imaging
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Physiology
  • Immunology

Research topics explored by Louis A. Matis encompass:

  • Monoclonal and Polyclonal Antibodies Research
  • HER2/EGFR in Cancer Research
  • Radiopharmaceutical Chemistry and Applications
  • Asthma and respiratory diseases
  • Inhalation and Respiratory Drug Delivery
  • Respiratory and Cough-Related Research
  • CAR-T cell therapy research

Some of their recent papers are:

  • O82 A phase 1 dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies, 2020, Oral Presentations
  • Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma, 2022, Journal of Allergy and Clinical Immunology
  • 1060 EVOLVE™: a novel costimulatory T cell engager platform engineered for the treatment of immune suppressive tumors, 2022, Regular and Young Investigator Award Abstracts

Frequent coauthors collaborating with Louis A. Matis include:

  • Shane A. Olwill
  • Sarina A. Piha-Paul
  • Johanna C. Bendell
  • Anthony Tolcher
  • Sara A. Hurvitz

The main publication venues appearing in their recent work are:

  • Oral Presentations
  • Journal of Allergy and Clinical Immunology
  • Regular and Young Investigator Award Abstracts

Best Publications

  • The Role of Fas in Autoimmune Diabetes

    Alexander V Chervonsky;Yi Wang;F.Susan Wong;Irene Visintin

  • Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

    Yi Wang;Scott A. Rollins;Joseph A. Madri;Louis A. Matis

  • The nature of major histocompatibility complex recognition by γδ T cells

    Hansjörg Schild;Nasim Mavaddat;Nasim Mavaddat;Christa Litzenberger;Elliot W. Ehrich

  • Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5

    Yi Wang;Qile Hu;Joseph A. Madri;Scott A. Rollins

  • Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv

    Thomas C. Thomas;Scott A. Rollins;Russell P. Rother;Michelle A. Giannoni

  • Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion Role of the Terminal Complement Components and Inhibition by Anti-C5 Therapy

    Antti P. Vakeva;Azin Agah;Scott A. Rollins;Louis A. Matis

  • In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B.

    B L Rellahan;L A Jones;A M Kruisbeek;A M Fry

  • Correlations between T-cell specificity and the structure of the antigen receptor.

    Pamela J. Fink;Louis A. Matis;David L. McElligott;Michael Bookman

  • Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass

    Jane C. K. Fitch;Scott Rollins;Louis Matis;Bernadette Alford

  • Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection

    William L. Fodor;Barry L. Williams;Louis A. Matis;Joseph A. Madri

  • Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules

    Louis A. Matis;Laurie H. Glimcher;William E. Paul;Ronald H. Schwartz

  • Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.

    L Racioppi;F Ronchese;L A Matis;R N Germain

  • Monoclonal antibody against an Ir gene product

    Ethan A. Lerner;Louis A. Matis;Charles A. Janeway;Patricia P. Jones

  • Composition and method for treating glomerulonephritis and other inflammatory diseases

    Mark J Evans;Louis Matis;Eileen Elliott Mueller;Steven H Nye

  • Major histocompatibility complex-linked specificity of γδ receptor-bearing T lymphocytes

    Louis A. Matis;Randy Cron;Jeffrey A. Bluestone

  • The Fine Specificity of Antigen and la Determinant Recognition by T Cell Hybridoma Clones Specific for Pigeon Cytochrome c

    Stephen M. Hedrick;Louis A. Matis;Toby T. Hecht;Lawrence E. Samelson

  • Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.

    C. S. Rinder;H. M. Rinder;B. R. Smith;J. C. K. Fitch

  • A role for complement in antibody-mediated inflammation: C5 deficient DBA/1 mice are resistant to collagen-induced arthritis

    Yi Wang;Jane Kristan;Liming Hao;Catherine S. Lenkoski

  • Self-reactive γδ T cells are eliminated in the thymus

    Alexander L. Dent;Louis A. Matis;Farideh Hooshmand;Suzanne M. Widacki

  • Selection of amino acid sequences in the beta chain of the T cell antigen receptor

    Stephen M. Hedrick;Isaac Engel;David L. McElligott;Pamela J. Fink

Frequent Co-Authors

Russell P. Rother
Russell P. Rother Tetherex Pharmaceuticals
Stephen M. Hedrick
Stephen M. Hedrick University of California, San Diego
Ronald H. Schwartz
Ronald H. Schwartz National Institutes of Health
Jeffrey A. Bluestone
Jeffrey A. Bluestone University of California, San Francisco
Yi Wang
Yi Wang Cornell University
Dan L. Longo
Dan L. Longo Harvard University
Gregory L. Stahl
Gregory L. Stahl Brigham and Women's Hospital
Charles A. Janeway
Charles A. Janeway Yale University
William E. Paul
William E. Paul National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their knowledge in Immunology, related online degrees in the healthcare field offer flexible routes to complement and enhance your career. Many professionals are choosing to pursue an online BSN programs for non nurses, designed to help individuals without prior nursing experience transition smoothly into nursing roles.

If you're looking for a faster pathway, accelerated BSN programs for non nurses offer an intensive curriculum that allows students to earn their Bachelor of Science in Nursing degree in a shortened timeframe. These programs are ideal for students eager to enter the healthcare workforce quickly.

For those considering entry-level nursing positions, exploring accredited LPN programs easy to get into can provide a practical and efficient start. Licensed Practical Nurse (LPN) programs typically require less time to complete and pave the way for hands-on patient care roles.

Additionally, if your goal is to advance clinical expertise, easiest NP program options are available to help registered nurses become Nurse Practitioners. These programs focus on specialized skills and can open doors to higher responsibility and better compensation in healthcare settings.

Best Scientists Citing Louis A. Matis

Trending Scientists

Recently Published Articles